2162 Results

People

  1. Dee
    Dee
  2. Vickers
    Vickers
  3. Shaha
    Shaha
  4. Morrow
    Morrow
  5. Tuttle
    Tuttle
  6. Adusumilli
    Adusumilli
  7. Breitbart
    Breitbart
  8. Rosa
    Rosa
  9. Rusch
    Rusch
  10. Molena
    Molena

Groups

  1. Department of Medicine (580)
  2. Surgery (559)
  3. Solid Tumor Oncology Division (324)
  4. GSK Faculty (307)
  5. Population Sciences Research Program (253)
  6. Sloan Kettering Institute Postdocs (251)
  7. Survivorship Research (225)
  8. Hematologic Malignancies, Division of (186)
  9. Center for Hematologic Malignancies (164)
  10. Graduate Medical Education (160)
  1. "Editorial"
Formats
  1. Editorial (2162)
Groups
  1. Department of Medicine (580)
  2. Surgery (559)
  3. Solid Tumor Oncology Division (324)
  4. GSK Faculty (307)
  5. Population Sciences Research Program (253)
  6. Sloan Kettering Institute Postdocs (251)

More Groups

People
  1. William Rosa (52)
  2. Edward Christopher Dee (51)
  3. Andrew Vickers (35)
  4. Ashok Shaha (30)
  5. Daniela Molena (29)
  6. Monica Morrow (24)

More People

Years
  1. 2025 (160)
  2. 2024 (305)
  3. 2023 (353)
  4. 2022 (363)
  5. 2021 (358)
  6. 2020 (342)

More Years

Publications
  1. Annals of Surgical Oncology (121)
  2. Journal of Clinical Oncology (62)
  3. Journal of Thoracic and Cardiovascular Surgery (52)
  4. European Urology (37)
  5. JAMA Oncology (36)
  6. Clinical Cancer Research (35)

More Publications

Publishers
  1. Elsevier Inc. (250)
  2. Springer (178)
  3. Elsevier Science, Inc. (165)
  4. Lippincott Williams & Wilkins (115)
  5. Nature Publishing Group (107)
  6. American Medical Association (96)

More Publishers

Results (2162)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In defense of P values
    Editorial

    Begg, C. B.
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save
  • FDA approves nivolumab plus ipilimumab for previously untreated unresectable malignant pleural mesothelioma - Comment
    Editorial

    Zauderer, M. G.
    Oncology (Norwalk) (2020)

    Fulltext@MSK | Save
  • Intratumor heterogeneity reflects clinical disease course
    Editorial

    Iacobuzio-Donahue, C. A.; Litchfield, K.; Swanton, C.
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • A roadmap for the next decade in cancer research
    Editorial

    Bernards, R.; Jaffee, E.; Joyce, J. A.; Lowe, S. W.; Mardis, E. R.; Morrison, S. J.; Polyak, K.; Sears, C. L.; Vousden, K. H.; Zhang, Z.
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Use of positron emission tomography imaging: Another nonbiological source of racial disparities in US cancer care
    Editorial

    Mitchell, A. P.; Bach, P. B.
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Modified routine cardiac imaging surveillance of adult cancer patients and survivors during the COVID-19 pandemic
    Editorial

    Calvillo-Argüelles, O.; Abdel-Qadir, H.; Ky, B.; Liu, J. E.; Lopez-Mattei, J. C.; Amir, E.; Thavendiranathan, P.
    JACC: CardioOncology (2020)

    Fulltext@MSK | Save
  • How we manage patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic
    Editorial

    Rossi, D.; Shadman, M.; Condoluci, A.; Brown, J. R.; Byrd, J. C.; Gaidano, G.; Hallek, M.; Hillmen, P.; Mato, A.; Montserrat, E.; more...
    HemaSphere (2020)

    Fulltext@MSK | Save
  • Molecular downstaging: A new paradigm for neoadjuvant endocrine therapy
    Editorial

    Ferraro, E.; Fornier, M. N.
    Annals of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Weight-based dosing of pembrolizumab every 6 weeks in the time of COVID-19
    Editorial

    Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Skin cancer management during the COVID-19 pandemic
    Editorial

    Thomas, J.; Rossi, A. M.
    Cutis (2020)

    Fulltext@MSK | Save